High-Dose Chemotherapy in Breast Cancer

Author： Lake Diana E.   Hudis Clifford A.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.64, Iss.17, 2004-01, pp. : 1851-1860

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lower costs with sequential high-dose chemotherapy in breast cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 422, 2003-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

High-dose chemotherapy regimen well tolerated in breast cancer

By  

Inpharma, Vol. 1, Iss. 1320, 2002-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

High-Dose Chemotherapy and Stem Cell Support for Breast Cancer: Where Are We Now?

By Gerrero R.M.   Stein S.   Stadtmauer E.A.  

Drugs & Aging, Vol. 19, Iss. 7, 2002-01 ,pp. : 475-485

Adis International

Access to resources Recommend Favorite

Pharmacodynamics of High-Dose Chemotherapy

By  

Current Drug Metabolism, Vol. 2, Iss. 1, 2001-03 ,pp. : 53-66

Bentham Science Publishers

Access to resources Recommend Favorite

High-dose vs approved-dose fulvestrant for ER+ breast cancer

By  

Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite